Curaleaf Holdings (CURLF) Goodwill (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Goodwill of $635.1 million for Q4 2025, up 0.99% year-on-year from $628.9 million in Q4 2024, and up 0.99% on a QoQ basis from $628.9 million in Q4 2024.
Curaleaf Holdings (CURLF) Goodwill (2019 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Goodwill for 7 consecutive years, with $635.1 million the latest figure, recorded in Q4 2025.
- Quarterly Goodwill rose 0.99% year-over-year to $635.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $635.1 million (up 0.99% YoY) and the FY2025 annual result came in at $635.1 million, up 0.99% from the prior year.
- Goodwill climbed to $635.1 million in Q4 2025 per CURLF's latest filing, from $628.9 million in the prior quarter.
- Over the last five years, Goodwill for CURLF reached as high as $665.0 billion in Q1 2022 and fell as low as $469.8 million in Q1 2021.
- A 5-year average of $44.9 billion and a median of $630.9 million in 2024 frame the typical range for Goodwill.
- Annual changes were most pronounced in 2022 — Goodwill surged 141448.24% — and 2024, when it slipped 6.69%.
- Year by year, Goodwill stood at $571.7 million in 2021, then climbed by 9.35% to $625.1 million in 2022, then gained by 0.24% to $626.6 million in 2023, then increased by 0.36% to $628.9 million in 2024, then advanced by 0.99% to $635.1 million in 2025.
- According to Business Quant data, Goodwill over the past three periods registered $635.1 million, $628.9 million, and $634.6 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 635.12 Mn |
| Dec 31, 2024 | 628.88 Mn |
| Sep 30, 2024 | 634.62 Mn |
| Jun 30, 2024 | 630.95 Mn |
| Dec 31, 2023 | 626.63 Mn |
| Sep 30, 2023 | 667.26 Mn |
| Jun 30, 2023 | 676.17 Mn |
| Dec 31, 2022 | 625.13 Mn |
| Sep 30, 2022 | 673.64 Mn |
| Jun 30, 2022 | 661.87 Mn |
| Mar 31, 2022 | 665.05 Bn |
| Dec 31, 2021 | 571.65 Mn |
| Sep 30, 2021 | 512.61 Mn |
| Jun 30, 2021 | 583.25 Mn |
| Mar 31, 2021 | 469.84 Mn |
| Dec 31, 2020 | 539.29 Mn |
| Sep 30, 2020 | 439.32 Mn |
| Dec 31, 2019 | 69.33 Mn |